A New Era in Schizophrenia Care: National Council for Mental Wellbeing and Bristol Myers Squibb Collaborate to Advance Evidence-Based Care Models

Go back to A New Era in Schizophrenia Care: National Council for Mental Wellbeing and Bristol Myers Squibb Collaborate to Advance Evidence-Based Care Models
Bristol-Myers Squibb (NYSE: BMY) Delayed: 54.00 --0 (-0%)
Previous Close $54.00    52 Week High $77.12 
Open $54.00    52 Week Low $49.03 
Day High $54.00    P/E 35.06 
Day Low $54.00    EPS $1.54 
Volume 65,855